These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 16130106

  • 1. Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies.
    Lee M, Bard F, Johnson-Wood K, Lee C, Hu K, Griffith SG, Black RS, Schenk D, Seubert P.
    Ann Neurol; 2005 Sep; 58(3):430-5. PubMed ID: 16130106
    [Abstract] [Full Text] [Related]

  • 2. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
    Bard F, Barbour R, Cannon C, Carretto R, Fox M, Games D, Guido T, Hoenow K, Hu K, Johnson-Wood K, Khan K, Kholodenko D, Lee C, Lee M, Motter R, Nguyen M, Reed A, Schenk D, Tang P, Vasquez N, Seubert P, Yednock T.
    Proc Natl Acad Sci U S A; 2003 Feb 18; 100(4):2023-8. PubMed ID: 12566568
    [Abstract] [Full Text] [Related]

  • 3. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL, Currie JR, Mehta PD, Potempska A, Hwang YW, Wegiel J.
    Biochemistry; 2003 Oct 14; 42(40):11682-92. PubMed ID: 14529278
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR, Capetillo-Zarate E, Schultz C, Rüb U, Saido TC, Yamaguchi H, Haass C, Griffin WS, Del Tredici K, Braak H, Ghebremedhin E.
    Acta Neuropathol; 2005 Nov 14; 110(5):459-71. PubMed ID: 16195918
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R, Dolezal O, Waddington L, Hattarki MK, Cappai R, Masters CL, Hudson PJ, Wark KL.
    Protein Eng Des Sel; 2009 Mar 14; 22(3):199-208. PubMed ID: 18927231
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development of Abeta terminal end-specific antibodies and sensitive ELISA for Abeta variant.
    Horikoshi Y, Sakaguchi G, Becker AG, Gray AJ, Duff K, Aisen PS, Yamaguchi H, Maeda M, Kinoshita N, Matsuoka Y.
    Biochem Biophys Res Commun; 2004 Jul 02; 319(3):733-7. PubMed ID: 15184044
    [Abstract] [Full Text] [Related]

  • 16. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.
    Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO.
    Nat Med; 2003 Apr 02; 9(4):448-52. PubMed ID: 12640446
    [Abstract] [Full Text] [Related]

  • 17. [Immunologic tolerance of anti-Abeta antibody in the sera of AD patients].
    Yang ZY, Wang HQ, Xu J, Xie Y, Yuan QF, Yao ZB.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct 02; 23(10):929-31. PubMed ID: 17908502
    [Abstract] [Full Text] [Related]

  • 18. Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides.
    Mruthinti S, Buccafusco JJ, Hill WD, Waller JL, Jackson TW, Zamrini EY, Schade RF.
    Neurobiol Aging; 2004 Sep 02; 25(8):1023-32. PubMed ID: 15212827
    [Abstract] [Full Text] [Related]

  • 19. Abeta species removal after abeta42 immunization.
    Nicoll JA, Barton E, Boche D, Neal JW, Ferrer I, Thompson P, Vlachouli C, Wilkinson D, Bayer A, Games D, Seubert P, Schenk D, Holmes C.
    J Neuropathol Exp Neurol; 2006 Nov 02; 65(11):1040-8. PubMed ID: 17086100
    [Abstract] [Full Text] [Related]

  • 20. Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice.
    Seabrook TJ, Thomas K, Jiang L, Bloom J, Spooner E, Maier M, Bitan G, Lemere CA.
    Neurobiol Aging; 2007 Jun 02; 28(6):813-23. PubMed ID: 16725229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.